FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Major players included in the Gastroesophageal Reflux Disease Treatment Market:

Gastroesophageal Reflux Disease Treatment Market is estimated to record a CAGR of over 4% during the forecast period 2020 to 2027.
The augmentation of the market can be credited to unhealthy lifestyle choices, rising awareness pertaining to GERD and technological advancements.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
AstraZeneca
Boston Scientific Corporation
Eisai Co., Ltd.
EndoGastric Solutions, Inc.
EndoStim BV
GlaxoSmithKline Plc.
Ironwood Pharmaceuticals, Inc.
Jeil Pharmaceutical Holdings Inc.
Johnson
Johnson
Teva Pharmaceutical Industries Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Gastroesophageal Reflux Disease Treatment Market Segmentation:

By Drug Class
Antacids
Proton Pump Inhibitors
Rabeprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Dexlansoprazole
Histamine-2 (H2) Blocker Receptor
Famotidine
Cimetidine
Ranitidine
Dopamine Receptor Antagonist
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Treatment Market By Drug Class and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report

You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1 . Years Considered for the Study
  3.2 . Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1 . Secondary Data
  1.1.1 . Key Data from Secondary Sources
  1.2 . Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Global Gastroesophageal Reflux Disease Treatment Market Variables, Trends
- Scope
  1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Gastroesophageal Reflux Disease Treatment Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Gastroesophageal Reflux Disease Treatment Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Global Gastroesophageal Reflux Disease Treatment Market, By Drug Class Historical Analysis and Forecast 2020-2027 (USD Million)
- 1. Antacids
  2. Proton Pump Inhibitors
  2.1. Rabeprazole
  2.2. Esomeprazole
  2.3. Lansoprazole
  2.4. Omeprazole
  2.5. Pantoprazole
  2.6. Dexlansoprazole
  3. Histamine-2 (H2) Blocker Receptor
  3.1. Famotidine
  3.2. Cimetidine
  3.3. Ranitidine
  4. Dopamine Receptor Antagonist
8. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2020-2027
9. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
- 1. Introduction
  2. Regional Market Trends
  3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
  3.1. Brazil
  3.2. Venezuela
  3.3. Argentina
  3.4. Rest of Latin America
  4. Market Size (USD Million) Forecast for Latin America 2020-2027
10. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Switzerland
  2.9. Rest of Western Europe
11. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
  2.1. Japan
  2.2. China
  2.3. Singapore
  2.4. India
  2.5. Australia and New Zealand
  2.6. ASEAN
  2.7. South Korea
  2.8. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
12. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
  2.1. Saudi Arabia
  2.2. UAE
  2.3. South Africa
  2.4. Egypt
  3. Market Size (USD Million) Forecast for MEA 2020-2027
13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
- 1. AstraZeneca
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Boston Scientific Corporation
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Eisai Co., Ltd.
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. EndoGastric Solutions, Inc.
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. EndoStim BV
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. GlaxoSmithKline Plc.
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Ironwood Pharmaceuticals, Inc.
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Jeil Pharmaceutical Holdings Inc.
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Johnson
  Johnson
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Teva Pharmaceutical Industries Ltd.
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
14. FutureWise SME key takeaway points for Client

Data Pack license: Data Pack license: $1850

Single user license: Single user license: $4250

Multi user license: Multi user license: $5450

Corporate license: Corporate license: $7800

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients